13th International Conference on the Molecular Biology and Pathogenesis of Clostridia (ClostPath 13)

总结 1995年在亚利桑那州的图森首次举行的国际分子生物学会议和 梭菌的发病机制（ClostPath）汇集了学者，临床医生和行业 科学家自成立以来，ClostPath会议一直是讨论 关于致病梭菌的最新研究和临床发现。在过去的5 - 10 多年来，该领域在引入突变的可靠和简单方法方面取得了迅速进展 转化成其他被认为是遗传上难以处理的生物体。因此， 揭示基本原理的有影响力的研究数量迅速增加 发病机制。此外，随着DNA的生成越来越容易， 测序，宏基因组/微生物组的比较，在梭菌导致新的 新的探索领域和新的假设。由于这些原因，必须继续执行 传统的面对面会议，讨论这些发现在亲密的设置。ClostPath 13 会议将于2023年9月19日至23日在加拿大班夫举行，并将为 传播新的想法和发现。 ClostPath会议将包括一位特邀主旨发言人和12位特邀全体会议 扬声器.每个受邀演讲者将标题之一的会议：基因调控; 一个健康;-组学;治疗与保健;生理学;微生物组学; Torhu Shimizu讲座; 毒素;孢子;微生物-微生物相互作用;宿主对感染的反应.在每一次会议上， 将有从符合会议主题的提交摘要中选择的口头报告。 将选择摘要，以提高初级科学家和科学家的知名度， 根据代表性的人口统计数据，并允许我们的主持人的不同地理位置。还有， 青年科学家将被选中主持每一次会议。这样的曝光会让 这些新兴的科学家在科学界有更多的曝光。 ClostPath 13的目标是继续（i）提供一个场地， 介绍关于致病性梭菌的前沿研究;以及（ii）鼓励 青年科学家和初级教员参加每次全体会议。这些 目标将由两个目标支持：目标1是提供支持 青年科学家和来自不同人口群体的科学家的发展。目标2是提供 设置，促进思想，假设和创新实验的轻松交流 战略布局

Summary First held in Tuscon, AZ in 1995, the International Conferences on the Molecular Biology and Pathogenesis of Clostridia (ClostPath) bring together academics, clinicians, and industry scientists. Since its inception, the ClostPath conferences have been a popular forum to discuss the latest research and clinical findings regarding pathogenic Clostridia. Over the past 5 – 10 years, the field has seen a rapid advance in reliable and easy methods to introduce mutations into organisms that were otherwise considered genetically intractable. Because of this, there has been a rapid increase in the number of impactful studies that shed light on the fundamental mechanisms of pathogenesis. Moreover, with the ever-increasing ease of generating DNA sequencing, metagenomic / microbiome comparisons in the Clostridia have led to new hypotheses and new areas of exploration. For these reasons, it is imperative to continue with the tradition of face-to-face meetings to discuss these findings in intimate settings. The ClostPath 13 conference will be held September 19 – 23, 2023 in Banff, Canada and will provide a forum for the dissemination of new ideas and findings. The ClostPath conference will consist of an invited Keynote speaker and 12 invited plenary speakers. Each of the invited speakers will headline one of the sessions on: Gene Regulation; One Health; -omics; Treatments & Healthcare; Physiology; Microbiome; Torhu Shimizu Lecture; Toxins; Spores; Microbe – Microbe Interactions; Host Response to Infection. In each session, there will be oral presentations chosen from submitted abstracts that fit the session topic. Abstracts will be chosen so as to increase the visibility of junior scientists and scientists from under representative demographics and allow for diverse geography of our presenters. Also, Young Scientists will be chosen to moderate each of the sessions. This type of exposure will allow these burgeoning scientists to have an increased exposure in the scientific community. The objectives for the ClostPath 13 will be to continue to (i) provide a venue to allow for the presentation of cutting-edge research on pathogenic Clostridia; and (ii) encourage the participation of young scientists and junior faculty in each of the plenary sessions. These objectives will be supported by two Aims: Aim 1 is to provide an environment that supports the development of young scientists and scientists from diverse demographics. Aim 2 is to provide a setting that promotes the easy exchange of ideas, hypotheses, and innovative experimental strategies.